Published in J Biol Chem on June 15, 2016
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
A large-scale, consortium-based genomewide association study of asthma. N Engl J Med (2010) 9.17
The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc (2015) 8.53
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol (2002) 7.60
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity (1997) 5.23
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 4.14
The interleukin-1 family: back to the future. Immunity (2013) 3.90
Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol (2012) 2.83
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem (2004) 2.60
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med (2007) 2.59
Post-translational modifications in signal integration. Nat Struct Mol Biol (2010) 2.23
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc Natl Acad Sci U S A (2006) 1.88
Improved model quality assessment using ProQ2. BMC Bioinformatics (2012) 1.70
Structural insights into the assembly and activation of IL-1β with its receptors. Nat Immunol (2010) 1.32
Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem (2011) 1.28
IL-36 in psoriasis. Curr Opin Pharmacol (2012) 1.20
Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One (2013) 1.10
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A (2012) 1.09
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J Leukoc Biol (2015) 1.09
Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A (2013) 1.09
IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol (2014) 1.08
Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol (2012) 1.06
Biology of IL-36 cytokines and their role in disease. Semin Immunol (2013) 1.01
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage. J Immunol (2015) 0.97
FlexPred: a web-server for predicting residue positions involved in conformational switches in proteins. Bioinformation (2008) 0.92
Molecular determinants of agonist and antagonist signaling through the IL-36 receptor. J Immunol (2014) 0.83
The structural basis for receptor recognition of human interleukin-18. Nat Commun (2014) 0.83
Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor. J Biol Chem (2015) 0.77
Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor. J Biol Chem (2015) 0.77